InnovaRx Innova Health Strategies

F16.90

Hallucinogen use, unspecified, uncomplicated

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 6 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 3 never code together
F16.9code
Excludes1
  • hallucinogen abuse (F16.1-)F16.1-
  • hallucinogen dependence (F16.2-)F16.2-
F01-F99chapter
Excludes2
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)R00-R99

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 4
F16code
Includes
  • ecstasy
  • PCP
  • phencyclidine
F01-F99chapter
Includes
  • disorders of psychological development
Index entries leading here 2
  • Use (of)
  • LSD reaction (acute) (without dependence) F16.90
Alongside this code 6 same parent — F16.9
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
F16.9
Block
F10-F19
Siblings
6

Present FY2024–FY2027.